Aimmune Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update by longitudeadmin | Mar 3, 2016 | Portfolio News
Commentary in The American Journal of Medicine Reinforces the Value of the Corus CAD Test in Evaluating Symptomatic Patients With Suspected Obstructive Coronary Artery Disease by longitudeadmin | Mar 2, 2016 | Portfolio News
Corcept Therapeutics Announces 2015 Financial Results by longitudeadmin | Mar 1, 2016 | Portfolio News
Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial Results by longitudeadmin | Feb 25, 2016 | Portfolio News
Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results by longitudeadmin | Feb 23, 2016 | Portfolio News
